Ambassador Advisors »

Halozyme Therapeutics shares owned by Ambassador Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Ambassador Advisors from 13F filings

Historical chart of Ambassador Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Ambassador Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Ambassador Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.1M 63k 64.63
2025-12-31 $1.6M 23k 67.30

More positions owned by Ambassador Advisors

Amgen (AMGN)
Northern Lts Fd Tr Iv Inspire Corp Bd (IBD)
Northern Lts Fd Tr Iv Inspire Growth E (GLRY)
Illinois Tool Works (ITW)
Ishares Gold Tr Ishares New (IAU)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Etf Opportunities Trust Idx Dynamic Fixe (DYFI)
Totalenergies Se Act (TTE)
Northern Lts Fd Tr Iv Inspire Intl Etf (WWJD)
Strategy Eventide High Di (ELCV)
Palantir Technologies Cl A (PLTR)
Amphenol Corp Cl A (APH)
NVIDIA Corporation (NVDA)
Etf Opportunities Trust Idx Alternative (GLDB)
Crowdstrike Hldgs Cl A (CRWD)

View all positions for Ambassador Advisors

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co

View all funds holding Halozyme Therapeutics